{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:04:41Z","timestamp":1790417081936,"version":"4.1.0"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6,21]]},"DOI":"10.1093\/eurheartj\/ehs431","type":"journal-article","created":{"date-parts":[[2012,12,17]],"date-time":"2012-12-17T20:56:10Z","timestamp":1355777770000},"page":"1826-1833","source":"Crossref","is-referenced-by-count":448,"title":["Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction"],"prefix":"10.1093","volume":"34","author":[{"given":"Anders Berg","family":"J\u00f8rgensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Frikke-Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Sode","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peer","family":"Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rge G.","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tybj\u00e6rg-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,12,17]]},"reference":[{"key":"key\n\t\t\t\t20170515121336_EHS431C1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","year":"2007","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170515121336_EHS431C2","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/ana.22384","article-title":"Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population","volume":"69","year":"2011","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170515121336_EHS431C3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2796.2010.02333.x","article-title":"Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up","volume":"270","year":"2011","journal-title":"J Intern Med"},{"key":"key\n\t\t\t\t20170515121336_EHS431C4","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","year":"2011","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170515121336_EHS431C5","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","year":"2011","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515121336_EHS431C6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","article-title":"Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women","volume":"298","year":"2007","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170515121336_EHS431C7","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","year":"2009","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170515121336_EHS431C8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.CIR.60.3.473","article-title":"Atherogenesis: a postprandial phenomenon","volume":"60","year":"1979","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515121336_EHS431C9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/01.ATV.11.3.569","article-title":"Quantitative studies of transfer in vivo of low density, Sf 12\u201360, and Sf 60\u2013400 lipoproteins between plasma and arterial intima in humans","volume":"11","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"key\n\t\t\t\t20170515121336_EHS431C10","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.ATV.15.4.534","article-title":"Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media","volume":"15","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20170515121336_EHS431C11","doi-asserted-by":"crossref","first-page":"27941","DOI":"10.1074\/jbc.M403240200","article-title":"ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis","volume":"279","year":"2004","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170515121336_EHS431C12","doi-asserted-by":"crossref","first-page":"21553","DOI":"10.1074\/jbc.M411412200","article-title":"Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase","volume":"280","year":"2005","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170515121336_EHS431C13","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1021\/bi7000533","article-title":"Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family","volume":"46","year":"2007","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20170515121336_EHS431C14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1064852","article-title":"An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing","volume":"294","year":"2001","journal-title":"Science"},{"key":"key\n\t\t\t\t20170515121336_EHS431C15","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1194\/jlr.M400192-JLR200","article-title":"Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study","volume":"45","year":"2004","journal-title":"J Lipid Res"},{"key":"key\n\t\t\t\t20170515121336_EHS431C16","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1194\/jlr.M300251-JLR200","article-title":"The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore","volume":"44","year":"2003","journal-title":"J Lipid Res"},{"key":"key\n\t\t\t\t20170515121336_EHS431C17","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1194\/jlr.M300458-JLR200","article-title":"APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study","volume":"45","year":"2004","journal-title":"J Lipid Res"},{"key":"key\n\t\t\t\t20170515121336_EHS431C18","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1365-2796.2007.01912.x","article-title":"Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene","volume":"263","year":"2008","journal-title":"J Intern Med"},{"key":"key\n\t\t\t\t20170515121336_EHS431C19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng.75","article-title":"Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans","volume":"40","year":"2008","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170515121336_EHS431C20","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","year":"2010","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170515121336_EHS431C21","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","year":"2008","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20170515121336_EHS431C22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/MOL.0b013e32834477d2","article-title":"Genetic determinants of LDL, lipoprotein(a), triglyceride-rich lipoproteins and HDL: concordance and discordance with cardiovascular disease risk","volume":"22","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"key\n\t\t\t\t20170515121336_EHS431C23","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/euhj.2000.2305","article-title":"The Joint European Society of Cardiology\/American College of Cardiology Committee. Myocardial infarction redefined\u2014a consensus document of The Joint European Society of Cardiology\/American College of Cardiology Committee for the redefinition of myocardial infarction","volume":"21","year":"2000","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170515121336_EHS431C24","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/eurheartj\/ehm355","article-title":"Universal definition of myocardial infarction","volume":"28","year":"2007","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170515121336_EHS431C25","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1161\/01.ATV.19.6.1535","article-title":"Mutations in the lipoprotein lipase gene associated with ischemic heart disease in men. The Copenhagen city heart study","volume":"19","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20170515121336_EHS431C26","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1172\/JCI119323","article-title":"A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease","volume":"99","year":"1997","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170515121336_EHS431C27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0021-9150(02)00183-1","article-title":"Effect of gender on phenotypic expression of the S447X mutation in LPL: the Copenhagen City Heart Study","volume":"165","year":"2002","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20170515121336_EHS431C28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/oxfordjournals.aje.a010013","article-title":"Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies","volume":"150","year":"1999","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20170515121336_EHS431C29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: the difference between two estimates","volume":"326","year":"2003","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170515121336_EHS431C30","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0140-6736(10)60545-4","article-title":"Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170515121336_EHS431C31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/01.ATV.12.1.6","article-title":"Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits. Roles of plasma concentrations, extent of aortic lesion, and lipoprotein particle size as determinants","volume":"12","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"key\n\t\t\t\t20170515121336_EHS431C32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/138945009787846434","article-title":"Nonfasting hyperlipidemia and cardiovascular disease","volume":"10","year":"2009","journal-title":"Curr Drug Targets"},{"key":"key\n\t\t\t\t20170515121336_EHS431C33","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1161\/01.CIR.101.24.2777","article-title":"Cardiovascular disease mortality in familial forms of hypertriglyceridemia: a 20-year prospective study","volume":"101","year":"2000","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515121336_EHS431C34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198208053070601","article-title":"Increased lipoprotein-remnant formation in chronic renal failure","volume":"307","year":"1982","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515121336_EHS431C35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0021-9150(87)90130-4","article-title":"Increased cholesterol concentration in intermediate density lipoprotein fraction of normolipidemic non-insulin-dependent diabetics","volume":"63","year":"1987","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20170515121336_EHS431C36","first-page":"2835","article-title":"Type III hyperlipoproteinemia (dyslipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","year":"2001","edition":"8th ed"},{"key":"key\n\t\t\t\t20170515121336_EHS431C37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2003.12.003","article-title":"Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease","volume":"173","year":"2004","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20170515121336_EHS431C38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cca.2008.12.024","article-title":"The apolipoprotein A5\u20131131T > C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease","volume":"402","year":"2009","journal-title":"Clin Chim Acta"},{"key":"key\n\t\t\t\t20170515121336_EHS431C39","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1194\/jlr.M600233-JLR200","article-title":"Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study","volume":"47","year":"2006","journal-title":"J Lipid Res"},{"key":"key\n\t\t\t\t20170515121336_EHS431C40","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.metabol.2004.11.009","article-title":"Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese","volume":"54","year":"2005","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t20170515121336_EHS431C41","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.atherosclerosis.2006.04.009","article-title":"The -1131 T > C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study","volume":"191","year":"2007","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20170515121336_EHS431C42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.atherosclerosis.2004.04.024","article-title":"APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease","volume":"176","year":"2004","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20170515121336_EHS431C43","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijcard.2004.10.065","article-title":"Impact of APOA5\/A4\/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men","volume":"106","year":"2006","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20170515121336_EHS431C44","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515121336_EHS431C45","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1016\/j.jacc.2010.02.044","article-title":"PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses","volume":"55","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170515121336_EHS431C46","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cca.2009.03.051","article-title":"The correlation between TG vs remnant lipoproteins in the fasting and postprandial plasma of 23 volunteers","volume":"404","year":"2009","journal-title":"Clin Chim Acta"},{"key":"key\n\t\t\t\t20170515121336_EHS431C47","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.2174\/0929867054546609","article-title":"Clinical relevance of postprandial lipaemia","volume":"12","year":"2005","journal-title":"Curr Med Chem"},{"key":"key\n\t\t\t\t20170515121336_EHS431C48","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.299.21.2524","article-title":"Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease","volume":"299","year":"2008","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170515121336_EHS431C49","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1210\/jc.2008-1342","article-title":"Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease","volume":"94","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170515121336_EHS431C50","doi-asserted-by":"crossref","first-page":"E500","DOI":"10.1210\/jc.2010-0450","article-title":"Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease","volume":"95","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170515121336_EHS431C51","doi-asserted-by":"crossref","first-page":"E248","DOI":"10.1210\/jc.2011-1846","article-title":"LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals","volume":"97","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170515121336_EHS431C52","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study","volume":"380","year":"2012","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170515121336_EHS431C53","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515121336_EHS431C54"},{"key":"key\n\t\t\t\t20170515121336_EHS431C55","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515121336_EHS431C56","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1194\/jlr.M700362-JLR200","article-title":"Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency","volume":"49","year":"2008","journal-title":"J Lipid Res"},{"key":"key\n\t\t\t\t20170515121336_EHS431C57","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0021-9150(94)90129-5","article-title":"Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk","volume":"106","year":"1994","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20170515121336_EHS431C58","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1567-5688(11)70885-6","article-title":"HDL-C: role as a risk modifier","volume":"12","year":"2011","journal-title":"Atheroscler Suppl"},{"key":"key\n\t\t\t\t20170515121336_EHS431C59","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.108.804146","article-title":"Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction","volume":"118","year":"2008","journal-title":"Circulation"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/34\/24\/1826\/17050716\/ehs431.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T00:34:53Z","timestamp":1562459693000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1093\/eurheartj\/ehs431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,17]]},"references-count":59,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2012,12,17]]},"published-print":{"date-parts":[[2013,6,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehs431","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,17]]}}}